Company / Income Tax
Boston Scientific Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$493.0M
FY2025
5-year range
-$4.0B / $493.0M
FY2021-FY2025
Trend
+13.1%
vs FY2024
Sector context
#13 of 162
Health Care
What the data says
Among 162 Health Care companies, Boston Scientific is in the bottom 8% for income tax. Income Tax has fluctuated over the past 10 years, ranging from -$4.0B in FY2021 to $828M in FY2017.
Based on SEC 10-K filings.
$493M in FY2025 with a 3-year CAGR of +3.6%. Top quartile in the Health Care sector.
Increased from $393M to $493M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 162This company $493.0M Sector average $145.4M
▼
+239.1% above sector average
Key checks
Key Insights
- 3-year CAGR of +3.6%, indicating consistent growth.
- In FY2025, income tax increased 13.1% year-over-year.
- Ranks #13 out of 162 companies in the Health Care sector.
- Peak income tax was recorded in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $493.0M | +13.1% |
| FY2024 | $436.0M | +10.9% |
| FY2023 | $393.0M | -11.3% |
| FY2022 | $443.0M | +111.0% |
| FY2021 | -$4.0B | -1511.6% |
| FY2020 | -$249.0M | +93.8% |
| FY2019 | -$4.0B | -1511.6% |
| FY2018 | -$249.0M | -130.1% |
| FY2017 | $828.0M | +587.1% |
| FY2016 | -$170.0M | +58.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026